Tsinghua research team developed a brain pacemaker
Release date: 2008-01-23
Tsinghua research team developed a brain pacemaker
Parkinson's disease patients and epilepsy patients in China are expected to use China's own "cerebral pacemakers" in the near future to achieve long-lasting and comprehensive treatment of the disease. Recently, I learned from Tsinghua University that this low-cost, high-tech "brain pacemaker" was developed by a team of researchers from Tsinghua University in electronics, information, software, materials, manufacturing and other fields.
It is understood that the "brain pacemaker" mainly used for the treatment of Parkinson's disease was first applied to China's clinical practice in 1999, but so far, all kinds of products in the Chinese market have been monopolized by foreign companies, and the price is expensive, generally in the ten Tens of thousands of yuan, and after a few years to spend about 100,000 yuan to replace, greatly limiting this advanced technology to better serve our patients.
In response to the national conditions and the needs of patients, the research team of Tsinghua University has designed a new model of "cerebral pacemaker" for wireless charging or power supply from outside the body, once implanted for life, and greatly saved the cost of patients. Key technical studies of the second generation of implantable neurostimulator platforms have been completed.
Li Luming, director of the Institute of Human Machine and Environmental Engineering at the School of Aerospace and Aeronautics, Tsinghua University, said that the "brain pacemaker" is a crystallization of cross-integration of information, materials, manufacturing and other disciplines from an engineering perspective, representing many high-level engineering fields. The technical achievement is a real engineering research; at the same time, it must meet the medical principles and meet the needs of patients, which is the product of the combination of "medical workers".
As an expert in the national medical device technology development plan, Li Luming said that the localization and low cost of medical devices, especially high-end medical devices, is an important measure to solve the problem of expensive medical treatment and medical reform, and will play a role in China's pharmaceutical and health industries in the future. In a very critical role, colleges and universities should bear important responsibilities. ——Shanghai Medical Device Industry Association
Multi Enzyme,Feed Additives Enzymes,Feed Enzymes,Nsp Enzyme
Tangshan Finely Animal Care Co.,Ltd , https://www.faczyme.com